Aug 29, 2012, 09.59 PM IST

Hospira to buy manufacturing facility from Orchid Chemicals

Injectable generic drugs maker Hospira Inc said it plans to buy a factory and a research center from India-based Orchid Chemicals & Pharmaceuticals for USD 200 million.

Source: Reuters
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Hospira to buy manufacturing facility from Orchid Chemicals
Injectable generic drugs maker Hospira Inc said it plans to buy a factory and a research center from India-based Orchid Chemicals & Pharmaceuticals for USD 200 million.


The factory, located in Aurangabad in Maharashtra, manufactures active pharmaceutical ingredients. It was constructed in 2000 and has 640 employees.


The R&D facility in Chennai has about 160 scientific personnel.


Lake Forest, Illinois-based Hospira said it expects the acquisitions to reduce costs, help supply key antibiotic products and pave the way for development of active pharmaceutical ingredients.


Hospira estimates the deal to break even or slightly add to earnings per share in the first year after it closes - expectedly in the fourth quarter.


Shares of Hospira opened up slightly at USD 33.45 on the New York Stock Exchange on Wednesday.


Source: Reuters

Set email alert for

Action in Orchid Chemicals and Pharmaceuticals
Apple could add LinkedIn integration to iOS 7
Monsoon live: PM announces Rs 1000 cr as relief for Uttarakhand "Monsoon live: PM announces Rs 1000 cr as relief for Uttarakhand"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

Jun 19 2013, 12:44

Weak rupee to benefit export oriented IT cos: Dipan Mehta

- in MARKET OUTLOOK